v3.26.1
Reclassifications and Revisions of Prior Period Financial Statements - Schedule of Consolidated Statements of Operations (Details) - As adjusted [Member]
 12 Months Ended
Dec. 31, 2024
USD ($)
Schedule of Consolidated Statements of Operations [Line Items]  
Revenue $ 172,661
Cost of goods sold 43,634
Gross profit 129,027
Operating expenses:  
General and administrative expenses 1,563,328
Research and development expenses 850,261
Sales and marketing 2,721,981
Acquisition and integration 2,038,130
Depreciation and amortization
Total operating expenses 7,173,700
Loss from operations (7,044,673)
Change in fair value of SAFE notes (14,492,176)
Loss before income taxes (21,536,849)
Provision for income taxes 581
Net loss (21,537,430)
As previously reported [Member]  
Schedule of Consolidated Statements of Operations [Line Items]  
Revenue 172,661
Cost of goods sold 343,889
Gross profit (171,228)
Operating expenses:  
General and administrative expenses 3,588,548
Research and development expenses 759,967
Sales and marketing 2,524,930
Acquisition and integration
Depreciation and amortization
Total operating expenses 6,873,445
Loss from operations (7,044,673)
Change in fair value of SAFE notes (14,492,176)
Loss before income taxes (21,536,849)
Provision for income taxes 581
Net loss (21,537,430)
Reclassification [Member]  
Schedule of Consolidated Statements of Operations [Line Items]  
Revenue
Cost of goods sold (300,255)
Gross profit 300,255
Operating expenses:  
General and administrative expenses (2,025,220)
Research and development expenses 90,294
Sales and marketing 197,051
Acquisition and integration 2,038,130
Depreciation and amortization
Total operating expenses 300,255
Loss from operations
Change in fair value of SAFE notes
Loss before income taxes
Provision for income taxes
Net loss